Information Provided By:
Fly News Breaks for July 1, 2016
CXW, PCRX, MAN, QRVO, AVY
Jul 1, 2016 | 10:31 EDT
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Avery Dennison (AVY) downgraded two notches to Underperform from Buy at BofA/Merrill by analyst George Staphos, citing Avery's relatively high retail exposure, difficult comps, and relative valuation. BofA/Merrill's strategists are forecasting a UK recession, relative weakness in the GBP and Euro versus the dollar, and a slowdown in GDP in both the Euro-zone and US, resulting in Staphos trimming estimates. 2. Qorvo (QRVO) downgraded to Neutral from Buy at Mizuho, with analyst Vijay Rakesh citing macro uncertainties of Brexit, a muted second half demand environment, a seasonally weaker Samsung/China handset market, and share loss in QCT. 3. Manpower (MAN) downgraded to Equal Weight from Overweight at Barclays, with analyst Manav Patnaik citing the company's 64% exposure to Europe. 4. Pacira (PCRX) downgraded to Hold from Buy at Brean Capital, with analyst Jonathan Aschoff citing the FDA evaluating adverse event reports of local anesthetic systemic toxicity with Exparel. 5. Corrections Corp. (CXW) downgraded to Neutral from Buy at SunTrust, citing a California ballot initiative due to be voted on in November could enable the state to reduce its inmate population. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.